Search research articles
Contact Us
Filters
Showing results (31-40 of 687) with videos related to
Page
of 69
Sort By:
Hepatology (Baltimore, Md.)
|
September 3, 2010
PNPLeAse get the fats right: does lipogenesis or lipolysis cause NASH?
Geoffrey C Farrell
Hepatology (Baltimore, Md.)
|
November 24, 2004
Probing Prometheus: fat fueling the fire?
Geoffrey C Farrell
Digestive Diseases and Sciences
|
December 1, 1996
Two years versus six months of interferon therapy for chronic hepatitis C
G C Farrell
Journal of Gastroenterology and Hepatology
|
September 11, 1999
Immunosuppression and reactivation of hepatitis B in the lamivudine era: opportunities for prevention and exploitation?
G C Farrell
Drugs
|
November 21, 2000
Clinical potential of emerging new agents in hepatitis B
G C Farrell
Seminars in Liver Disease
|
May 23, 2002
Drugs and steatohepatitis
Geoffrey C Farrell
Australian Family Physician
|
March 1, 1995
Hepatitis C: a current perspective
G C Farrell
Journal of Gastroenterology and Hepatology
|
October 5, 2007
Déjà vu, mais pas en anglais! Precautionary notes on publishing the same article in two languages
Geoffrey C Farrell
The Medical Journal of Australia
|
January 31, 1976
Fanconi's familial hypoplastic anaemia with some unusual features
G C Farrell
Journal of Gastroenterology and Hepatology
|
January 1, 1991
Treatment of chronic hepatitis C with alpha-interferon
G C Farrell
Page
of 69
Search research articles
Search
Showing results (31-40 of 687) with videos related to
Sort By:
Page
of 69
Hepatology (Baltimore, Md.)
|
September 3, 2010
PNPLeAse get the fats right: does lipogenesis or lipolysis cause NASH?
Geoffrey C Farrell
Hepatology (Baltimore, Md.)
|
November 24, 2004
Probing Prometheus: fat fueling the fire?
Geoffrey C Farrell
Digestive Diseases and Sciences
|
December 1, 1996
Two years versus six months of interferon therapy for chronic hepatitis C
G C Farrell
Journal of Gastroenterology and Hepatology
|
September 11, 1999
Immunosuppression and reactivation of hepatitis B in the lamivudine era: opportunities for prevention and exploitation?
G C Farrell
Drugs
|
November 21, 2000
Clinical potential of emerging new agents in hepatitis B
G C Farrell
Seminars in Liver Disease
|
May 23, 2002
Drugs and steatohepatitis
Geoffrey C Farrell
Australian Family Physician
|
March 1, 1995
Hepatitis C: a current perspective
G C Farrell
Journal of Gastroenterology and Hepatology
|
October 5, 2007
Déjà vu, mais pas en anglais! Precautionary notes on publishing the same article in two languages
Geoffrey C Farrell
The Medical Journal of Australia
|
January 31, 1976
Fanconi's familial hypoplastic anaemia with some unusual features
G C Farrell
Journal of Gastroenterology and Hepatology
|
January 1, 1991
Treatment of chronic hepatitis C with alpha-interferon
G C Farrell
Page
of 69